缺血性脑血管病为临床常见病,近年来发病率逐年提高,发病年龄也出现年轻化趋势。进展型卒中是指局限性脑缺血症状逐渐进展,呈阶梯式加重,可持续6h以上乃至数天的缺血性脑血管病。我们联合应用东菱精纯克栓酶(DF-251)、血塞通治疗进展型卒中,并以血塞通作为对照药,共观察病例32 Ischemic cerebrovascular disease is a common clinical disease, the incidence in recent years increased year by year, the age of onset also appears younger trend. Progressive stroke refers to the gradual progress of localized ischemic symptoms, was stepped aggravating, more than 6h sustainable and even several days of ischemic cerebrovascular disease. We are using the combination of DF-251, Xuesaitong treatment of stroke, and Xuesaitong as a reference drug, a total of observed cases 32